William L Blalock (William Blalock)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Venues

Nutrients

Cancers

Journal of cellular physiology

Cells

Consiglio Nazionale delle Ricerche

East Carolina University Brody School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Consiglio Nazionale delle Ricerche Nov 01 2011

Italy

Ricercatore III Livello :: Istituto di Genetica Molecolare

Università di Bologna Apr 01 2009 - Oct 31 2011

Italy

Senior Research Scientist :: Human Anatomy

Università di Bologna Mar 01 2007 - Feb 28 2009

Italy

Research Fellow :: Human Anatomy

Centro di Biotecnologie Avanzate/Advanced Biotechnology Center May 15 2005 - Jan 15 2007

Italy

Senior Scientist :: Innovative Therapy

University of Florida Jul 01 2000 - Apr 30 2005

United States

Post-doctoral Research Associate :: Shands Cancer Center

Education History

East Carolina University Brody School of Medicine Aug 01 1995 - Jul 01 2000

United States

PHD :: Microbiology and Immunology

East Carolina University Aug 01 1992 - Aug 31 1997

United States

MSC :: Biology

Wake Forest University Aug 15 1987 - May 20 1991

United States

BSC :: School of Arts and Sciences

Publications

Sara Salucci, Alberto Bavelloni, Anna Bartoletti Stella, Francesco Fabbri, Ivan Vannini, Manuela Piazzi, Karyna Volkava, Katia Scotlandi, Giovanni Martinelli, Irene Faenza, William L Blalock
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling. Nutrients 15 (3) (2023)
Sara Salucci, Beatrice Aramini, Anna Bartoletti-Stella, Ilaria Versari, Giovanni Martinelli, William L Blalock, Franco Stella, Irene Faenza
Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches. Cancers 15 (12) (2023)
Manuela Piazzi, Alberto Bavelloni, Sara Salucci, Irene Faenza, William L Blalock
Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing. Genes 14 (7) (2023)
Sara Salucci, Alberto Bavelloni, Anna Bartoletti Stella, Francesco Fabbri, Ivan Vannini, Manuela Piazzi, Karyna Volkava, Katia Scotlandi, Giovanni Martinelli, Irene Faenza, William L Blalock
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling. Nutrients 15 (3) (2023)
Sara Salucci, Beatrice Aramini, Anna Bartoletti-Stella, Ilaria Versari, Giovanni Martinelli, William L Blalock, Franco Stella, Irene Faenza
Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches. Cancers 15 (12) (2023)
Elisa Schena, Elisabetta Mattioli, Chiara Peres, Laura Zanotti, Paolo Morselli, Patricia Iozzo, Maria Angela Guzzardi, Chiara Bernardini, Monica Forni, Salvatore Nesci, Massimiliano Caprio, Carolina Cecchetti, Uberto Pagotto, Elena Gabusi, Luca Cattini, Gina Lisignoli, William L Blalock, Alessandra Gambineri, Giovanna Lattanzi
Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction. Cells 12 (22) (2023)
Caterina Mancarella, Veronica Giusti, Giulia Caldoni, Maria Antonella Laginestra, Alessandro Parra, Lisa Toracchio, Giorgia Giordano, Laura Roncuzzi, Manuela Piazzi, William L Blalock, Marta Columbaro, Alessandra De Feo, Katia Scotlandi
Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells. Cancer gene therapy (2023)
Sara Salucci, Alberto Bavelloni, Anna Bartoletti Stella, Francesco Fabbri, Ivan Vannini, Manuela Piazzi, Karyna Volkava, Katia Scotlandi, Giovanni Martinelli, Irene Faenza, William L Blalock
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling. Nutrients 15 (3) (2023)
Manuela Piazzi, Alberto Bavelloni, Vittoria Cenni, Sara Salucci, Anna Bartoletti Stella, Enrica Tomassini, Katia Scotlandi, William L Blalock, Irene Faenza
Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells. Molecules (Basel, Switzerland) 27 (9) (2022)
Irene Faenza, William L Blalock
Innate Immunity: A Balance between Disease and Adaption to Stress. Biomolecules 12 (5) (2022)
Sara Salucci, Anna Bartoletti-Stella, Alberto Bavelloni, Beatrice Aramini, William L Blalock, Francesco Fabbri, Ivan Vannini, Vittorio Sambri, Franco Stella, Irene Faenza
Extra Virgin Olive Oil (EVOO), a Mediterranean Diet Component, in the Management of Muscle Mass and Function Preservation. Nutrients 14 (17) (2022)
William L Blalock
Opposing forces fight over the same ground to regulate interferon signaling. The Biochemical journal 478 (10) (2021)
Manuela Piazzi, Snezana Kojic, Cristina Capanni, Nemanja Stamenkovic, Alberto Bavelloni, Oriano Marin, Giovanna Lattanzi, William L Blalock, Vittoria Cenni
Ectopic Expression of Ankrd2 Affects Proliferation, Motility and Clonogenic Potential of Human Osteosarcoma Cells. Cancers 13 (2) (2021)
Manuela Piazzi, Alberto Bavelloni, Vittoria Cenni, Irene Faenza, William L Blalock
Revisiting the Role of GSK3, A Modulator of Innate Immunity, in Idiopathic Inclusion Body Myositis. Cells 10 (11) (2021)
Manuela Piazzi, Alberto Bavelloni, Sara Greco, Enrico Focaccia, Arianna Orsini, Stefania Benini, Marco Gambarotti, Irene Faenza, William L Blalock
Expression of the double-stranded RNA-dependent kinase PKR influences osteosarcoma attachment independent growth, migration, and invasion. Journal of cellular physiology 235 (2) (2019)
Alberto Bavelloni, Enrico Focaccia, Manuela Piazzi, Arianna Orsini, Giulia Ramazzotti, Lucio Cocco, William L Blalock, Irene Faenza
Therapeutic potential of nvp-bkm120 in human osteosarcomas cells. Journal of cellular physiology 234 (7) (2018)

William L Blalock.css-eqlu8i{font-size:small;padding-left:4px;} (William Blalock)

Publication Activity (10 Years)

Top Topics

Top Venues

William L Blalock (William Blalock)